Should I buy Adient (ADNT) stock or is it too late?

Adient · Consumer Discretionary · price $19

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: UBS — 58% of its targets hit on this sector (157 calls tested). It aims for $29 (+54 %), call made on August 7, 2026, maturing on August 7, 2027 (21 d ago).

The 2 reliable analysts $29+54 %

The 6 other firms $27+43 %

How to read it: the 2 reliable firms are not filtered by optimism — 2 aim above the price, 0 below, hence their $29 median. “The 6 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Adient

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
Morgan Stanley	61 %	+0.1 %	23	$21 +12%
Barclays	8 %	-18.6 %	12	$25 +33%
Wells Fargo	20 %	-20.7 %	20	$32 +70%
B of A Securities	18 %	-34.6 %	11	$20 +6%
Credit Suisse	83 %	+56.4 %	6	—
Keybanc	71 %	+26.6 %	7	—

In short — Should you invest in Adient? Is it too late, still worth it? Analysts are fairly positive (63% buy, median target $29, i.e. +51%), and the most reliable on ADNT targets even higher. But the stock is volatile, it pays virtually no dividend. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

63% of analysts rate it a buy (Buy consensus, 8 ratings) — a sign of market conviction.
Median price target $29, i.e. +51% from the current price ($19).
The most reliable firm on ADNT, Deutsche Bank (100% hit rate, 3 scored calls), targets $29 (call made on July 6, 2026, maturing on July 6, 2027) (+54%) in its most recent call.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 8 ratings, 3 are neutral.
A 12-month target is not a guaranteed path: the price can fall in the meantime.
Volatile stock: sharp swings — including steep drops — are part of its profile.
No dividend: your return depends only on price appreciation.

The analyst consensus on ADNT

Median target $29 (+51%) · 8 ratings · Buy consensus

Strong Buy00%

Buy563%

Hold338%

Sell00%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Adient now?

We won't decide for you. The facts: 63% of analysts rate it a buy, median target $29 (+51%), and Deutsche Bank (most reliable on ADNT, 100%) targets $29. Weigh that against valuation and volatility. This is not personalized advice.

Is it too late to invest in Adient?

Not according to analysts: the median target ($29) is still +51% above the current price ($19) (most reliable on ADNT: Deutsche Bank, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Adient still worth investing in?

It depends on the gap between the price ($19) and its estimated value: analysts target $29 on median (+51%), with 63% buys (most reliable on ADNT: Deutsche Bank, 100%). Cross-check with their real reliability on ADNT and the cautions above. Information, not advice.

What's the main risk in buying ADNT?

The consensus is not unanimous: of 8 ratings, 3 are neutral.

→ Go deeper: the full Adient profile (consensus, analyst reliability, price target, performance).